US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

35.93

-1.9783-5.22%

Post-market: 34.80-1.1315-3.15%16:10 EDT

Volume:606

Turnover:21.23K

Market Cap:2.69M

PE:- -

High:35.93

Open:34.74

Low:34.74

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.64

T/O Rate:0.81%

Dividend:0.76

Dividend Rate:2.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Gilead put volume heavy and directionally bearish

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live

MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":35.9315,"timestamp":1791489600000,"preClose":37.9098,"halted":0,"volume":606,"hourTrading":{"tag":"盘后","latestPrice":34.8,"preClose":35.9315,"latestTime":"16:10 EDT","volume":7,"amount":250.6575,"timestamp":1791490204511,"change":-1.1315,"changeRate":-0.03149,"amplitude":0},"delay":0,"changeRate":-0.05218439559164115,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Closed","change":-1.9783,"latestTime":"10-08 16:00:00 EDT","open":34.74,"high":35.9315,"low":34.74,"amount":21229,"amplitude":0.03143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":37.9098,"sharesOutstanding":100001,"nav":37.898,"aum":2842383.83,"dividendRate":0.021277,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.8,"preClose":35.9315,"latestTime":"16:10 EDT","volume":7,"amount":250.6575,"timestamp":1791490204511,"change":-1.1315,"changeRate":-0.03149,"amplitude":0},"volumeRatio":0.640998},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.640998,"shares":75001,"dividePrice":0.76452,"high":35.9315,"amplitude":0.03143,"preClose":37.9098,"low":34.74,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":35.9315,"eps":0,"divideRate":0.021277,"volume":606,"delay":0,"ttmEps":0,"open":34.74,"prevYearClose":31.065,"prevWeekClose":36.95,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":37.9097,"twentyDayClose":38.8987,"sixtyDayClose":31.7049},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672278203","title":"Moderna Inc. Stock Sheds 5.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672278203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672278203?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:33","pubTimestamp":1790800380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 5.4% to $192.57 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,861.06 and the Dow Jones Industrial Average falling 0.9% to 50,906.05.Moderna Inc. closed 7.8% short of its 52-week high of $208.90, which the company reached on September 29th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $264.74, Pfizer Inc. fell 0.7% to $28.52, and Gilead Sciences Inc. fell 1.47% to $149.05.Trading volume totaled 20.1 million, compared to the 50-day average of 19.4 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","TBXU","LU1778281490.HKD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","IBB","MRNY","IE00BSNM7G36.USD","BK4583","LU0058720904.USD","LU0289739699.SGD","LU0320765992.SGD","LU1934455194.USD","BK4585","LU1674673691.USD","LGHT","WDNA","BK4566","BBH","GNOM","SG9999015952.SGD","BK4550","BK4534","LU1037948897.HKD","LU0109394709.USD","BK4139","MRNX","BK4568","BMED","LU1023059063.AUD","LU1430594728.SGD","LU2089984988.USD","LU1934455277.USD","LU2087621335.USD","IE0002270589.USD","IBBQ","LU1066053197.SGD","LU1057294990.SGD","BK4532","LU2357627491.SGD","LU1934455863.HKD","MEDI","TMED","SG9999015945.SGD","BIB","BK4533","IDNA","MRNA","GILD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672078261","title":"Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2672078261","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672078261?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:14","pubTimestamp":1790799285,"startTime":"0","endTime":"0","summary":"Regeneron links 2026 CEO, CSO PSU awards to FDA filings, approvals and new-product revenue targets through 2035Regeneron set 2026 performance stock units for its CEO and CSO with a 10-year performance","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL6RTPN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2468319806.SGD","LU0114720955.EUR","BK4585","LU0823434583.USD","LU0823434740.USD","LU2237438978.USD","IBB","IBBQ","LU0889565916.HKD","BBH","LU1917777945.USD","LU2023250504.SGD","LU2106854487.HKD","LU0053666078.USD","LU2324357040.USD","TBXU","LU0058720904.USD","LU2089984988.USD","LU2362541513.USD","LU0109394709.USD","LU1974910355.USD","BK4139","LU2362540622.SGD","LU2362541273.HKD","BK4588","LU0823416689.USD","REGN","LU0882574055.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672784566","title":"Gilead put volume heavy and directionally bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2672784566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672784566?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:15","pubTimestamp":1790795714,"startTime":"0","endTime":"0","summary":"Bearish flow noted in Gilead (GILD) with 6,354 puts trading, or 4x expected. Most active are Nov-26 140 puts and 10/9 weekly 146 puts, with total v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-put-volume-heavy-and-directionally-bearish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4532","BK4568","LU1057294990.SGD","LU1839511570.USD","LU2087621335.USD","LU0889565916.HKD","LU1585245621.USD","BMED","LU0965509010.AUD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","TMED","LU1066051498.USD","IE00BSNM7G36.USD","BK4588","BBH","SG9999015986.USD","IBB","IE00BKVL7J92.USD","BIB","LU2112291526.USD","IBBQ","LU0289739699.SGD","LU1037948897.HKD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU0882574055.USD","LU2324357040.USD","MEDI","BK4585","LU1430594728.SGD","LU2357627491.SGD","LU0859254822.USD","BK4578","SG9999015952.SGD","SG9999015978.USD","IE00B3T34201.USD","BK4550","GILD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786096","title":"Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786096","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786096?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785810,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals, Inc. (REGN) has completed a Phase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regenerons-aln-f1202-safety-trial-marks-a-quiet-but-important-pipeline-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","LU2324357040.USD","LU0889565916.HKD","BK4585","ALN","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671778532","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2671778532","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671778532?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:19","pubTimestamp":1790781554,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.43% to 1,911.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company DBV Technologies , which rose 5.2% and 3.4% respectively. They were followed by biopharmaceutical company Cellectis  and internet browser company Opera , which were up 2.4% and 1.3% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and biopharmaceutical company argenx , which dropped 2.2% and 1.7% respectively. They were followed by healthcare tech company Royal Philips  and lender Banco Santander , which lost 1.2% and 1% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which advanced 7.9% and 4.9% respectively. They were followed by biotech firm Autolus Therapeutics  and biopharmace","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4521","LU2324357040.USD","TBXU","LU0823416689.USD","IE0002141913.USD","CLLS","WPP","SAN.AU","PUK","DAVA","LU0109394709.USD","TRVG","BK4007","OPRA","TRIB","IE00B2B36J28.USD","BK4134","SAN","NCNA","PHG","GSKH","IBB","GSIB","LU0084288595.USD","AUTL","ARGX","AFG","WPP.AU","BK4023","DAVA.AU","IE00BJJMRZ35.SGD","GSK","BK4082","BK4588","LU1983260115.SGD","IEUR","LFGY","GSK.UK","IE00BFTCPJ56.SGD","SQNS","BK4117","BK4162","BK7142","IE00B4R5TH58.HKD","LU0648005311.SGD","MREO","DBVT","FMED","LU0390134368.USD","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671520485","title":"MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2671520485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671520485?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:10","pubTimestamp":1790770233,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced that its clinical-stage agenT-797 iNKT platform has been selected as a therapeutic cell system within an Advance...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-selected-for-arpa-h-funded-initiative-to-advance-room-temp-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-selected-for-arpa-h-funded-initiative-to-advance-room-temp-cell-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","INKT","CNCR","IBBQ","FBT","GNOM","IBB","LFSC","SYNB","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206126","title":"Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206126?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:12","pubTimestamp":1790766720,"startTime":"0","endTime":"0","summary":"Biotech can't generate the revenue that investors expect, says Wall Street firmModerna was the target of a sell recommendation by Citi.After rallying almost seven-fold this year, Citi is now advising ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4139","LU0889565916.HKD","LGHT","LU0882574055.USD","LU0289739699.SGD","LU2023250504.SGD","BBH","BK4588","LU0109394709.USD","LU2468319806.SGD","BK4568","LU2362540622.SGD","GNOM","BK4551","MRNX","BK4585","LU0053666078.USD","LU2106854487.HKD","IBB","LU2362541513.USD","LU0114720955.EUR","LU1974910355.USD","BK4501","BK4533","LU1917777945.USD","LU0823416689.USD","REGN","TBXU","IBBQ","IDNA","LU2237438978.USD","LU0058720904.USD","LU0823434583.USD","LU0823434740.USD","LU0320765992.SGD","BK4534","LU2324357040.USD","BK4548","LU2089984988.USD","MRNA","ISBC","LU2362541273.HKD","BK4211","MRNY","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274431","title":"Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274431","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671274431?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:31","pubTimestamp":1790757060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rose 2.9% to 5.71 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 24613.27.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 33% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 6.3% and Amgen Inc. remained unchanged.Trading volume totaled 91.4 million shares, compared to the 50-day average of 81.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","PJP","BK1191","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","BK1589","BIB","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","BK1521","IE00BZ08YS42.EUR","LU0122379950.USD","LU0868494617.USD","01177","LU0289739699.SGD","LU1057294990.SGD","BK1515","IE00B4R5TH58.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK4533","BK4585","HK0000165453.HKD","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324755","title":"Moderna Inc. Stock Climbs 3.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324755?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:35","pubTimestamp":1790714100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 3.1% to $203.46 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $202.67, which the company achieved on September 25th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Pfizer Inc. remained unchanged, and Gilead Sciences Inc. fell 0.61% to $151.28.Trading volume totaled 13.1 million, compared to the 50-day average of 19.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU0965509283.SGD","IDNA","MRNY","BK4551","LU1571399168.USD","LU1430594728.SGD","LU0114720955.EUR","LU0058720904.USD","TMED","WDNA","LU1674673691.USD","LU0882574055.USD","LU1066053197.SGD","LU2468319806.SGD","LU2324357040.USD","MEDI","LU1934455194.USD","BBH","IBBQ","BK4534","LU1839511570.USD","MRNA","LU0320765992.SGD","LU0861579265.USD","LU1057294990.SGD","IE00B3T34201.USD","LU1934455277.USD","MRNX","LU0122379950.USD","BIB","IE00BKVL7J92.USD","BK4550","BMED","LGHT","LU0965508806.USD","LU0889565916.HKD","BK4533","LU0859254822.USD","BK4585","LU0289739699.SGD","LU0965509010.AUD","BK4501","BK4578","GNOM","LU2089984988.USD","IBB","GILD","TBXU","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671247515","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671247515","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671247515?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:34","pubTimestamp":1790714040,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.32% to $423.64 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.17% to 7,670.84 and Dow Jones Industrial Average  falling 0.26% to 51,349.92.This was the stock's third consecutive day of gains.Amgen Inc. closed 5.23% below its 52-week high of $447.03, which the company achieved on August 25th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 1.61% to $267.57, Pfizer Inc.  remained unchanged, and AbbVie Inc.  fell 1.12% to $263.29.Trading volume  eclipsed its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","LU1061106388.HKD","LU0122379950.USD","IE00BJJMRZ35.SGD","BIB","LU0320765992.SGD","LU2242646821.SGD","LU2242652126.USD","LU0868494617.USD","LU2468319806.SGD","LU1023059063.AUD","AMGN","BBH","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","04332","LU1571399168.USD","PJP","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4585","LU1983299246.USD","BK4599","IBB","BK4533","IE0002141913.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","BK4534","BK4588","BK4581","LU0058720904.USD","IE00BJT1NW94.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246994","title":"Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246994","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246994?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:39","pubTimestamp":1790699968,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  needs \"better\" terms from a potential renegotiated agreement with Sanofi  over their drug development collaboration, RBC said in a report Tuesday.The note said the firms have been providing breadcrumbs on ongoing negotiations. RBC conducted a buyside poll to gauge what investors may be expecting from a renegotiation to drive Regeneron shares.There was an almost even split between investors suggestingthat Dupixent follow-ons into the joint venture and better economics were sufficient and those wanting to see an additional sweetener in cash or another asset from Sanofi, the report said.\"Overall it suggests to us that REGN needs to come away with better terms on its follow-ons than what is currently the case for dupi, and perhaps could extract some additional upside in the form of cash or another joint asset from partner SNY,\" it said.RBC has a sector perform rating with a price target of $737.Price: 748.59, Change: -3.66, Percent Change: -0.49","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU2362541273.HKD","LU0882574055.USD","LU0823434583.USD","LU0320765992.SGD","LU0114720955.EUR","LU2089984988.USD","BBH","LU2023250504.SGD","IBB","BK4585","LU1974910355.USD","SNYNF","LU0058720904.USD","LU0823416689.USD","LU0289739699.SGD","BK4588","LU1917777945.USD","LU2362541513.USD","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","BK4007","LU0823434740.USD","REGN","TBXU","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD","SNY","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671243545","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29","url":"https://stock-news.laohu8.com/highlight/detail?id=2671243545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671243545?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:01","pubTimestamp":1790694066,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-09-29Nasdaq 100.NDXTop PerformersPercent ChangeLumentum Holdings Inc.LITE.OQ+6.7%ARM Holdings PLCARM.OQ+5.3%Nebius Group NVNBIS.OQ+5.0%CoreWeave, Inc.CRWV.OQ+4.3%Marvell Technology, Inc.MRVL.OQ+4.2%Bottom PerformersPercent ChangePalo Alto Networks, Inc.PANW.OQ-3.0%Walmart Inc.WMT.OQ-2.9%Ferrovial N.V.FER.OQ-2.3%T-Mobile US IncTMUS.OQ-2.1%Gilead Sciences, Inc.GILD.OQ-1.9%The Nasdaq 100.NDXgained 91.01 points, or 0.30%, to 30,367.82 and recorded no new highs and one new low. 37 stocks rose and 64 fell as declining issues outnumbered advancers by about a 1.7-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL8N45L1LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWU","NBIS","LU0109394709.USD","GB00BDT5M118.USD","MRVX","LU0267386448.USD","LITG","IBB","SG9999015952.SGD","LU1316542783.SGD","CRWG","LU1235294995.USD","LU0320765992.SGD","HAKY","LU1861215975.USD","LU2471134523.USD",".IXIC","07261","LU1804176565.USD","LU1303367103.USD","SG9999015945.SGD","TBXU","LU2471134796.USD","LU0048573561.USD","BK4609","XNTK","IE00B19Z8W00.USD","LU2322448957.HKD","BK4549","LITC","LU2357125470.USD","TQQQ","FER","LU2746668974.SGD","LU0266013472.USD","LU0642271901.SGD","LU0056508442.USD","LU0965509010.AUD","IE0001KFT4U8.USD","LU0012050646.USD","LU2357627491.SGD","LU0211327993.USD","09834","BK4532","LU0738911758.USD","LU1712237335.SGD","BK4566","ARM","IE00BMPRXR70.SGD","BK4504","LU1642822529.SGD","BK4561","LU1621768115.EUR","IE00B19Z9505.USD","LU1923622291.USD","LU2125154778.USD","BK4596","LU2286300806.USD","03086","LU0251131958.USD","LU1934455277.USD","LU2125154935.USD","LU2361044949.HKD","LU2458330169.SGD","LU1621767737.EUR","LU1988902786.USD","HK0000914686.HKD","LU2505996509.AUD","LU1066051498.USD","BK4568","BK4533","SPRX","LU0444971666.USD","LU1169590202.USD","MVLL","IE00B775SV38.USD","IBBQ","FSTA","TMED","LU2210150020.SGD","LU2247934214.USD","TMUS","LU2097829019.USD","LITX","07266","LU0289961442.SGD","LU0476273544.USD","LU1621768206.USD","LU0122379950.USD","BK4583","GTEK","SG9999001424.SGD","LU1267930573.SGD","LU1430594728.SGD","NBIZ","IE00BLSP4452.SGD","PSWD","LU0106261612.USD","LU0348723411.USD","LU1823568750.SGD","LU0320765489.SGD","LU2473716301.USD","LU0823421416.USD","LU0823434583.USD","LU1267930490.SGD","BBH","IE00BMPRXQ63.HKD","DTCR","LU1046421795.USD","LU0081259029.USD","LU1116320901.HKD","LU0256863902.USD","WUGI","LU0823421333.USD","BK4560","LU0061475181.USD","HK0000819398.USD","LU2592432038.USD","LU0310800379.SGD","LU1066051225.USD","IE0004091025.USD","LU0310799852.SGD","BK4534","NEBX","QDEC","NBIC","LU1852331112.SGD","IE00BN8TJ469.HKD","LU2361045086.USD","LU2355687059.USD","ARTY","PANW","LU2381873111.SGD","NJAN","LU0957791311.USD","PALU","RTH","LU2468319806.SGD","IGV","IE00BD4GTW91.USD","LU1037948541.HKD","LU2087625088.SGD","WCBR","PANG","LU1917777945.USD","LU0289739699.SGD","IE00B3S45H60.SGD","LU2095319765.USD","LU0329931173.USD","IE00BLSP4239.USD","LU1623119135.USD","LU1983260115.SGD","IE00B3T34201.USD","LU0661504455.SGD","QQQ","LU2360107168.USD","BK4597","LU2290526834.HKD","CWVX","BK4604","WMTI","LU2430703251.USD","BK4515","BUG","LU1621767810.EUR","LU1815336760.USD","LU1992135399.USD","LU1506573853.SGD","NBIL","SOXY","LU2265009873.SGD","LU0889565916.HKD","LAZR","LU1720051108.HKD","LU1066051811.HKD","LU0719512351.SGD","IE00B1BXHZ80.USD","LU0553294199.USD","LU0708994859.HKD","BK4077","LU0265550946.USD","LU0823431563.USD","LU0154236417.USD","BK4543","IE000M9KFDE8.USD","IE00BD4GTV84.USD","LU2089985449.USD","LU0211328371.USD","QLD","07522","CWII","SMHX","WMT","LU0861579265.USD","07568","BK4588","LU0240877869.USD","LITE","LU0511384066.AUD","CIBR","SPAM","BK4598","PSQ","LU1934455194.USD","LU1992135472.HKD","BK4581","LU0823434740.USD","LU0234570918.USD","SG9999015978.USD","BK4132","MRVU","03455","LU2505996681.GBP","TQQY","LU1066053197.SGD","LU1037948897.HKD","BMED","NOCT","LU1023059063.AUD","LU0823416689.USD","IE00BD4GTT62.SGD","LU2357305700.SGD","LUMA","LU0114720955.EUR","LU0289960550.SGD","LU2746668461.USD","LU0187121727.USD","QQQX","LU0444973449.USD","GPIQ","LITZ","LU2458330243.SGD","BIB","LU2360032135.SGD","NDX","09086","LU2543165471.USD","LU0353189763.USD","LU1814569148.SGD","LU0742534661.SGD","LU0949170772.SGD","LU0950373646.USD","LU2750360997.AUD","LU0238689110.USD","LU2506951792.HKD","LU1116320737.USD","AIFD","LU0096362180.USD","CRWX","QMAR","FTXL","QID","LU2931357623.SGD","02834","LU0029864427.USD",".HXC","LU0274383776.USD","IE00B7SZLL34.SGD","BK4559","LU0128525929.USD","LU1674673691.USD","LU0353189680.USD","HK0000914660.USD","LU1815333072.USD","LU0276348264.USD","LU2272731600.USD","LU0882574055.USD","LU2125909759.SGD","LU0823414551.USD","LU2471134879.HKD","TRFK","AIPI","LU2264538146.SGD","LU0329931090.USD","LU2098885051.SGD","IE0002270589.USD","XLP","FDTX","LU1934455863.HKD","LU0965508806.USD","EGGY","LU1839511570.USD","QQQM","LU2461242641.AUD","IE0034235188.USD","LU0208291251.USD","LU0149725797.USD","LU2294711713.HKD","LU2361044865.SGD","LU1069347547.HKD","LU2272731782.SGD","UGE","NAPR","LU1084165304.USD","CRWV","FAI","IE00BZ1G4Q59.USD","LU0314106906.USD","BK4116","LU2125909916.SGD","BK4550","IE00BMPRXN33.USD","LU0417517546.SGD","LU1003077747.HKD","BK4097","MRVL","LU0061474960.USD","PALD","LU2384288077.EUR","LU1778281490.HKD","LU1119994496.HKD","LU0205194284.USD","BK4129","LU2249611893.SGD","LU0256863811.USD","LU0957808578.USD","LU1232071149.USD","CORD","LU2244417387.USD","IE00BBT3K403.USD","LU1989764748.USD","LU1035773651.USD","ARMG","NJUL","LU0531971165.HKD","LU1261432733.SGD","ARMU","LU2317271919.USD","LU1169589451.USD","LU2023250843.SGD","ARMA","IE00BSNM7G36.USD","IHAK","AIS","LU2112291526.USD","LU0545039389.USD","LU2430703095.HKD","QQQA","GILD","LU1064131342.USD","LU0289739343.SGD","LU1548497426.USD","WCLD","LU1974910355.USD","IE00B19Z3581.USD","LU1585245621.USD","ARMW","LU2210149790.SGD","LU2471134952.CNY","LU0061474705.USD","LU0640476718.USD","FXL","LU0175139822.USD","IE00B19Z8X17.USD","LU1674673428.USD","LU0170899867.USD","LU2322448791.USD","LU1861559042.SGD","LU1861558580.USD","LU0070302665.USD","LU0127658192.USD","LU1861220033.SGD","LU0077335932.USD","LU0786609619.USD","SQQQ","LU2272731865.HKD","LU0859254822.USD","LU1366192091.USD","LU0965509283.SGD","LU0965509101.SGD","LU2089984988.USD","LU0082616367.USD","LU1720051017.SGD","LU0251142724.SGD","LU1989764664.SGD","LU2106854487.HKD","LU1571399168.USD","IE00B19Z3B42.SGD","LU0205193047.USD","LU1280957306.USD","LU2023250504.SGD","LU0097036916.USD","LU2324357040.USD","LU0823414478.USD","BK4139","LITU","SG9999000418.SGD","LU0314104364.USD","LU0058720904.USD","FOTO","BK4605","LU0265550359.USD","LU2750360641.GBP","03034","BK4155","BK4020","BK4141","CLOD","LU1061106388.HKD","LU2087621335.USD","NBIG","SG9999015986.USD","TRUO","MEDI","IE0004086264.USD","LU0823431647.USD","LU1057294990.SGD","LU0240878834.USD","BK4585","BK4578","LU2430703178.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671142248","title":"Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2671142248","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671142248?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:31","pubTimestamp":1790692316,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks'  Datapoints and Apheris said Tuesday that AbbVie , argenx , Lundbeck, and Takeda  will join them as founding members of the Antibody Developability Consortium.The consortium is designed to help pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field's largest standardized antibody developability dataset, according to a statement.The companies said that each founding member will contribute proprietary antibody sequences, with Ginkgo Datapoints filling any remaining capacity from publicly available sources to reach a total of 10,000 antibodies.The consortium is targeting an initial dataset by early 2027, they added.Price: 11.01, Change: +0.55, Percent Change: +5.26","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B42XCP33.USD","LU0868494708.USD","LU1732800096.USD","AGNG","MEDX","LU1585245621.USD","BK4534","IBB","LU1670628061.USD","IE000BZT7R73.USD","IE0002141913.USD","IE0004445239.USD","IXJ","LU0211327993.USD","ABBV","LU1061106388.HKD","GLAM","JDOC","PPH","IE0002270589.USD","LU0661504455.SGD","LU1670627923.USD","LU2357627491.SGD","PJP","TRUH","XLV","LU0029864427.USD","SG9999015945.SGD","IYH","LU0889565916.HKD","IE00BSNM7G36.USD","LU2023251221.USD","BK4533","RXL","IE00B3PB1722.GBP","FHLC","TBXU","FMED","IE00BGHQF631.EUR","TAK","LU0689472784.USD","DNA.AU","BK4007","ARGX","IE00BJT1NW94.SGD","FTXH","LU0128525929.USD","VHT","LU0320765646.SGD","DNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","LU0823416689.USD","LU2468319806.SGD","HCSG","LU2362540622.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0114720955.EUR","OCUL","LU2488822045.USD","LABU","LU2237438978.USD","XBI","LU2106854487.HKD","BK4581","XLV","LU0882574055.USD","IBB","TBXU","BK4585","LU0823434740.USD","LU1974910355.USD","BK4139","BK4007","SMMT","LU0053666078.USD","BK4588","LU0889565916.HKD","LU2362541273.HKD","LU0109394709.USD","LU0128526141.USD","LU0058720904.USD","LU2089984988.USD","BK4137","LU1917777945.USD","BBH","REGN","LU0029874061.USD","LU2362541513.USD","LU0823434583.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215313","title":"Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215313?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:31","pubTimestamp":1790677875,"startTime":"0","endTime":"0","summary":"A federal judge has dismissed a securities fraud lawsuit against Regeneron Pharmaceuticals ($REGN) and several of its executives, with the court di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","LU0114720955.EUR","IBBQ","LU0823434740.USD","LU0109394709.USD","LU1974910355.USD","LU0823434583.USD","LU0882574055.USD","BBH","LU2362541273.HKD","LU2089984988.USD","IBB","BK4588","LU2106854487.HKD","LU0320765992.SGD","LU2468319806.SGD","LU1917777945.USD","LU2023250504.SGD","LU0289739699.SGD","REGN","LU2362540622.SGD","BK4585","TBXU","LU2237438978.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0053666078.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290718","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290718?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:30","pubTimestamp":1790674217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT), Envista Holdings...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU2362541273.HKD","LU0882574055.USD","IE0034390439.USD","NVST","LU0823434583.USD","LU0320765992.SGD","LU0130103400.USD","LU0114720955.EUR","LU0477156797.USD","LU2089984988.USD","LU0130518102.USD","BBH","BK4082","LU2023250504.SGD","LU0029874061.USD","BK4137","LU1201861165.SGD","LU0648000940.SGD","XLV","IBB","BK4585","LU1974910355.USD","LU0058720904.USD","LU0823416689.USD","BK4588","BK4581","HCSG","LU0289739699.SGD","XBI","IE00B19Z6F94.USD","LU1917777945.USD","LU2362541513.USD","LU0128526141.USD","LU0109394709.USD","LU2362540622.SGD","LU2468319806.SGD","BK4139","FDMT","LU0823434740.USD","REGN","LABU","TBXU","IBBQ","LU0053666078.USD","LU2106854487.HKD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1066051498.USD","LU2357627491.SGD","BBH","LU0234570918.USD","SG9999015986.USD","TMED","LU0965509283.SGD","BK4566","BK4550","IE0002270589.USD","LU0965509010.AUD","LU1934455277.USD","LU1057294990.SGD","LU0122379950.USD","LU0823416689.USD","LU1839511570.USD","SG9999015978.USD","LU1934455194.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","IBB","IE00B7SZLL34.SGD","BK4585","IE00B19Z3B42.SGD","BK4139","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1934455863.HKD","LU0859254822.USD","MEDI","BK4568","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU0965509101.SGD","BIB","LU2089984988.USD","GILD","LU1674673428.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","MRNY","PINK","IYH","TEVA","XLVX","SYNB","NVIB","RSPH","LFSC","BK4559","MEDI","GDOC","BK4557","BK4566","BK4588","BBP","BMED","GNMX","BK4007","IBB","LU2324357040.USD","IDNA","IEIH","PSCH","BK4584","FRTY","LABU","LU1983299246.USD","TECB","TBXU","BK4596","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1983299246.USD","BK4599","NDAQ","LU0058720904.USD","BBH","BCDF","IE00BFTCPJ56.SGD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","IE0002141913.USD","AMGN","BK4112","LU2242646821.SGD","PJP","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2242652126.USD","LU2468319806.SGD","LU2210149790.SGD","SG9999014021.USD","IE00B4R5TH58.HKD","SG9999014039.USD","BK4533","IBB","BK4566","LU0289739699.SGD","BK4585","TBXU","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","IBBQ","LU1061106388.HKD","LU2089984988.USD","SG9999001440.SGD","LU0889565916.HKD","IE00BQXX3D17.EUR","LU1571399168.USD","LU2112291526.USD","SG9999014013.SGD","BK4534","PBE","LU0320765992.SGD","BK4139","IE00BKPKM429.USD","IE00BN0W2T93.GBP","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","BK4588","BK4139","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","BK4585","LU2089984988.USD","TBXU","LU0823434583.USD","KOD","BK4505","LU0320765992.SGD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","BBH","BK4007","LU0053666078.USD","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362540622.SGD","LU2237438978.USD","LU0058720904.USD","LU2106854487.HKD","IBBQ","LU0114720955.EUR","REGN","OCUL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}